REAL WORLD USE OF IXAZOMIB WITH LENALIDOMIDE AND DEXAMETHASONE FOR PATIENTS WITH RELAPSED AND RELAPSED REFRACTORY MULTIPLE MYELOMA

被引：0
|
作者：
Ziff, M. [1 ]
Cheesman, S. [1 ]
Kyriakou, C. [1 ]
Mehta, A. [1 ]
Papanikolaou, X. [1 ]
Rabin, N. [1 ]
Wechalekar, A. [1 ]
Yong, K. [1 ]
Popat, R. [1 ]
机构：
[1] Univ Coll London Hosp NHS Fdn Trust, London, England
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1975
引用
收藏
页码：786 / 787
页数：2
相关论文
共 50 条
  • [21] Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma
    Dabkara, Deepak
    Bajpai, Jyoti
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2008, 29 (03) : 10 - 13
  • [22] Ixazomib-lenalidomide-dexamethasone in routine clinical practice: effectiveness in relapsed/refractory multiple myeloma
    Hajek, Roman
    Minarik, Jiri
    Straub, Jan
    Pour, Ludek
    Jungova, Alexandra
    Berdeja, Jesus G.
    Boccadoro, Mario
    Brozova, Lucie
    Spencer, Andrew
    Rhee, Frits van
    Vela-Ojeda, Jorge
    Thompson, Michael A.
    Abonour, Rafat
    Chari, Ajai
    Cook, Gordon
    Costello, Caitlin L.
    Davies, Faith E.
    Hungria, Vania T. M.
    Lee, Hans C.
    Leleu, Xavier
    Puig, Noemi
    Rifkin, Robert M.
    Terpos, Evangelos
    Usmani, Saad Z.
    Weisel, Katja C.
    Zonder, Jeffrey A.
    Barinova, Magda
    Kuhn, Matyas
    Silar, Jiri
    Capkova, Lenka
    Galvez, Kenny
    Lu, Jin
    Elliott, Jennifer
    Stull, Dawn Marie
    Ren, Kaili
    Maisnar, Vladimir
    FUTURE ONCOLOGY, 2021, 17 (19) : 2499 - 2512
  • [23] Quality of life and response to treatment with ixazomib-lenalidomide-dexamethasone (IRd) in patients with relapsed/refractory multiple myeloma (RRMM) in a real-world setting
    Ionova, T.
    Anchukova, L.
    Dubov, S.
    Esenina, T.
    Ivanova, L.
    Kaplanov, K.
    Kochkareva, Y.
    Kopylova, A.
    Kravchuk, T.
    Levanov, A.
    Li, O.
    Nikitina, T. P.
    Rukavitsyn, O.
    Saraeva, N.
    Savinova, M.
    Shelekhova, T.
    Simashova, P.
    Shirokova, M.
    Vinogradova, O.
    Volkova, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S655 - S655
  • [24] CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN JAPANESE PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Ri, M.
    Suzuki, K.
    Chou, T.
    Sugiura, I.
    Takezako, N.
    Sunami, K.
    Ishida, T.
    Izumi, T.
    Ozaki, S.
    Iida, S.
    HAEMATOLOGICA, 2016, 101 : 787 - 788
  • [25] Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma
    Siegel, D. S.
    Richardson, P.
    Dimopoulos, M.
    Moreau, P.
    Mitsiades, C.
    Weber, D.
    Houp, J.
    Gause, C.
    Vuocolo, S.
    Eid, J.
    Graef, T.
    Anderson, K. C.
    BLOOD CANCER JOURNAL, 2014, 4 : e182 - e182
  • [26] Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma
    D S Siegel
    P Richardson
    M Dimopoulos
    P Moreau
    C Mitsiades
    D Weber
    J Houp
    C Gause
    S Vuocolo
    J Eid
    T Graef
    K C Anderson
    Blood Cancer Journal, 2014, 4 : e182 - e182
  • [27] Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma
    Nikhil C Munshi
    Constantine Mitsiades
    Paul G Richardson
    Kenneth C Anderson
    Nature Clinical Practice Oncology, 2008, 5 : 374 - 375
  • [28] Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma
    Munshi, Nikhil C.
    Mitsiades, Constantine
    Richardson, Paul G.
    Anderson, Kenneth C.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (07): : 374 - 375
  • [29] Real-world evidence of Carfilzomib, Lenalidomide and Dexamethasone (KRD) Scheme in patients with relapsed / refractory multiple myeloma
    Antoni Garcia-Guiñon
    Paola Andrea Charry
    María Jimenez
    Josep Sarra
    Izarbe Delgado
    Laura Segura de la Torre
    Marta Santaliestra
    Marta Garcia-Pintos
    Yolanda Gonzalez
    Alicia Senin
    Cristina Motlló
    Eugènia Abella
    Elena Cabezudo
    Miquel Granell
    Esther Sancho
    María José Herranz
    Yasmina Seres
    Mercedes Gironella
    Juan Alfons Soler
    Josep Maria Marti-Tutusaus
    Ran Ben Azaiz
    Carlos Fernandez de Larrea
    Annals of Hematology, 2025, 104 (2) : 1177 - 1186
  • [30] Real-world data on the effectiveness and safety of Ixazomib-Lenalidomide-Dexamethasone therapy in relapsed/refractory multiple myeloma patients: a multicenter experience in Turkey
    Bakirtas, Mehmet
    Dal, Mehmet Sinan
    Yigenoglu, Tugce Nur
    Giden, Asli Odabasi
    Serin, Istemi
    Basci, Semih
    Kalpakci, Yasin
    Korkmaz, Serdal
    Ekinci, Omer
    Albayrak, Murat
    Basturk, Abdulkadir
    Ozatli, Duzgun
    Dogu, Mehmet Hilmi
    Hacibekiroglu, Tuba
    Cakar, Merih Kizil
    Ulas, Turgay
    Miskioglu, Mine
    Gulturk, Emine
    Eser, Bulent
    Altuntas, Fevzi
    JOURNAL OF CHEMOTHERAPY, 2023, 35 (06) : 563 - 569
12345